Pivotal Studies Lead to New Treatment Landscape for Metastatic HER2-Positive Breast Cancer
A review of patient assessment, treatment options, and management strategies for adverse effects in patients with metastatic HER2-positive breast cancer were presented at the 2023 ONA Summit.
